Epstein Secrets

n. § 726.105(1)(a). Jane Doe has made such a showing, as explained in the next paragraph in text. 5 For this reason, Epstein’s citation of In re Stewart, 280 B.R. 268, 285 (Bkrtcy. M.D. Fla. 2001), is not on point. In that case, the plaintiff had merely made allegations without providing any support

ive, and opportunity to fraudulently transfer assets.” Jane Doe’s Motion to Restrain Fraudulent Transfer of Assets at 11 (quoting United States v. Sparks, 265 F.3d 825, 830 (9th Cir. 2001)).2 Epstein completely misses the point of Jane Doe’s means, motive, and opportunity argument, construing it as s

tor is fraudulently transferring assets. Jane Doe fails to point to one iota of evidence that Epstein is fraudulently transferring assets. In In re Stewart, 280 B.R. 268 (M.D. Fla. 2001), proceedings were brought to set aside certain transfers of the debtor as fraudulent to creditors. The bankruptcy tr

Epstein is fraudulently transferring assets because he purportedly has the means, the motive and the opportunity to do so, citing United States v. Sparks, 265 F.3d 825, 830 (9th Cir. 2001). See Injunction Motion (DE #165) at 11. Sparks is completely inapposite as it concerned whether probable cause fo

lenes) and Preliminary Measurements of their Young's Modulus, Hardness and Thermal Stability", Neenan, T. X., Callstrom, M. R., Scarmoutzos, L. M., Stewart, K. R. and Whitesides, G. M., Macromolecules, 1988, 21, 3525.3528. 239. "Formation of Two-Component Surfaces by the Spontaneous Assembly of Monola

4, 925-930. 371. "Neuraminidase Resistant Hemagglutination Inhibitors: Acrylamide Copolymers Containing a C- Glycoside of N-Acetylneuraminic Acid", Sparks, M. A., Williams, K. W. and Whitesides, G. M., J. Med. Chem., 1993, 36, 778-783. 370. "Synthesis of Methyl a-Sialosides N-substituted with Large A